聚胺-药物结合物:它们是否会增加药物活性?
Filippo Basagni1, Giambattista Marotta1, Michela Rosini1
1Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.
Molecules (Basel, Switzerland)
|June 10, 2023
概括
将聚胺尾巴与药物结合,通过改善细胞吸收来提高药物的有效性. 本综述强调了过去十年来用于各种治疗领域的聚胺合物.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
背景情况:
- 多氨酸对细胞功能至关重要.
- 在各种疾病中观察到高聚胺运输.
- 将多胺与生物活性分子结合,可以增强药理学特征.
研究的目的:
- 审查过去十年开发的聚胺合物.
- 根据治疗领域对这些合物进行分类.
- 突出成就并指导未来的聚胺合物开发.
主要方法:
- 关于聚胺合物的文献综述.
- 基于治疗应用的分类 (抗癌,抗微生物,抗氧化剂,神经保护).
- 对归因于聚胺结合的药理学增强的分析.
主要成果:
- 许多聚胺合物已被开发用于各种治疗应用.
- 聚胺促进通过输送系统增强细胞和亚细胞吸收.
- 结合策略已经成功地提高了各种生物活性剂的疗效.
结论:
- 聚胺结合是一种经过验证的策略,用于改善药物输送和疗效.
- 未来的研究应该专注于优化聚胺合物用于特定的病理条件.
- 聚胺输送系统为药物递送增强提供了一个有希望的目标.
相关概念视频
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
Phase II Conjugation Reactions: Overview
249
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
249
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Prodrugs
2.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.7K
Principles of Drug Action
6.2K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.2K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
303
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
303


